PL2176299T3 - Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003) - Google Patents

Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003)

Info

Publication number
PL2176299T3
PL2176299T3 PL08751340T PL08751340T PL2176299T3 PL 2176299 T3 PL2176299 T3 PL 2176299T3 PL 08751340 T PL08751340 T PL 08751340T PL 08751340 T PL08751340 T PL 08751340T PL 2176299 T3 PL2176299 T3 PL 2176299T3
Authority
PL
Poland
Prior art keywords
exopolysaccharide
ncimb
bifidobacterium infantis
infantis
bifidobacterium
Prior art date
Application number
PL08751340T
Other languages
English (en)
Inventor
Raymond Alan Grant
Liam O'mahony
Barbara Sheil
Original Assignee
Alimentary Health Limited
The Procter And Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alimentary Health Limited, The Procter And Gamble Company filed Critical Alimentary Health Limited
Publication of PL2176299T3 publication Critical patent/PL2176299T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
PL08751340T 2007-05-04 2008-05-02 Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003) PL2176299T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92424207P 2007-05-04 2007-05-04
EP08751340.4A EP2176299B1 (en) 2007-05-04 2008-05-02 Exopolysaccharide from bifidobacterium infantis 35624 (ncimb 41003)

Publications (1)

Publication Number Publication Date
PL2176299T3 true PL2176299T3 (pl) 2017-11-30

Family

ID=39563583

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08751340T PL2176299T3 (pl) 2007-05-04 2008-05-02 Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003)

Country Status (13)

Country Link
US (2) US8357794B2 (pl)
EP (1) EP2176299B1 (pl)
JP (1) JP2010526055A (pl)
KR (1) KR20100020938A (pl)
CN (1) CN101835806B (pl)
BR (1) BRPI0811451A2 (pl)
CA (1) CA2686314C (pl)
CO (1) CO6251326A2 (pl)
ES (1) ES2640351T3 (pl)
PL (1) PL2176299T3 (pl)
RU (1) RU2511044C2 (pl)
WO (1) WO2008135959A1 (pl)
ZA (1) ZA200907742B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
WO2010023178A1 (en) * 2008-08-28 2010-03-04 Chr. Hansen A/S Pharmaceuticals comprising a bacterial polysaccharide
CN107320480A (zh) 2009-02-24 2017-11-07 里特制药股份有限公司 益生素制剂和使用方法
JP5455203B2 (ja) * 2009-08-03 2014-03-26 森下仁丹株式会社 フィルム製剤およびその製造方法
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
KR101569043B1 (ko) 2013-08-28 2015-11-13 한국식품연구원 바실러스 서브틸리스 j-92 및 이를 이용하여 세포외다당류를 대량 생산하는 방법
US20180280453A1 (en) 2015-08-27 2018-10-04 Alimentary Health Limited Use of bifidobacterium longum and an exopolysaccharide produced thereby
US10233433B2 (en) 2015-08-27 2019-03-19 Alimentary Health Ltd. Bifidobacterium longum
RU2662310C9 (ru) * 2015-12-04 2018-09-21 Виктор Вениаминович Тец Средство (варианты) и способы восстановления микрофлоры
AU2016368527B2 (en) * 2015-12-11 2023-01-12 Precisionbiotics Group Limited Bifidobacterium longum for treating obesity and associated metabolic disorders
IT201600122724A1 (it) * 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
WO2018158309A1 (en) * 2017-02-28 2018-09-07 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
WO2018158306A1 (en) * 2017-02-28 2018-09-07 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
WO2018180728A1 (ja) * 2017-03-30 2018-10-04 森永乳業株式会社 炎症制御遺伝子の発現促進用組成物
CN106977617B (zh) * 2017-04-12 2019-08-20 常州谙美生物科技有限公司 益生菌中具有抗紫外、修复敏感皮肤及抗衰老功能的多糖及其分离方法和应用
CN117752697A (zh) * 2018-01-29 2024-03-26 精密生物集团有限公司 一种用于预防和治疗肠易激综合征的组合产品
WO2019145570A1 (en) * 2018-01-29 2019-08-01 Alimentary Health Limited A combination product for prophylaxis and treatment of irritable bowel syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61257930A (ja) * 1985-05-09 1986-11-15 Morinaga Milk Ind Co Ltd 感染防御剤
CH679677A5 (pl) * 1989-09-29 1992-03-31 Om Lab Sa
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius

Also Published As

Publication number Publication date
EP2176299A1 (en) 2010-04-21
US8357794B2 (en) 2013-01-22
CO6251326A2 (es) 2011-02-21
ZA200907742B (en) 2010-07-28
AU2008246968A1 (en) 2008-11-13
CA2686314C (en) 2015-10-13
KR20100020938A (ko) 2010-02-23
WO2008135959A1 (en) 2008-11-13
CN101835806B (zh) 2012-11-07
RU2511044C2 (ru) 2014-04-10
BRPI0811451A2 (pt) 2014-11-04
US20130261071A1 (en) 2013-10-03
RU2009140353A (ru) 2011-06-10
EP2176299B1 (en) 2017-07-05
CN101835806A (zh) 2010-09-15
US20110046084A1 (en) 2011-02-24
JP2010526055A (ja) 2010-07-29
CA2686314A1 (en) 2008-11-13
ES2640351T3 (es) 2017-11-02

Similar Documents

Publication Publication Date Title
PL2176299T3 (pl) Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003)
PL2134833T3 (pl) Probiotyczny szczep Bifidobacterium
GB2460781B (en) Probiotic bifidobacterium strains
PL2352389T3 (pl) Bifidobacterium longum
PL2034848T3 (pl) Bakteria Streptococcus thermophilus
HK1152968A1 (en) New probiotic bifidobacterium longum
GB0715936D0 (en) Mutant bacterium
PL380803A1 (pl) Nowy szczep Bifidobacterium longum
HU0700337D0 (en) Mutant bradyrhizobium bacterium
GB0702034D0 (en) Avt 1
PL380804A1 (pl) Nowy szczep Lactobacillus rhamnosus
GB0723669D0 (en) T m 4
GB0714675D0 (en) Note 014
GB0714688D0 (en) Note 006
GB0714674D0 (en) Note 013
GB0714678D0 (en) Note 017
GB0714677D0 (en) Note 016
GB0714672D0 (en) Note 011
GB0714679D0 (en) Note 018
GB0714680D0 (en) Note 019
GB0714681D0 (en) Note 020
GB0714682D0 (en) Note 021
GB0714683D0 (en) Note 001
GB0714684D0 (en) Note 002
GB0714685D0 (en) note 003